title: Lymphotoxin and LIGHT signaling pathways and target genes.
abstract: Lymphotoxins (LT alpha and LT beta), LIGHT [homologous to LT, inducible expression, competes with herpes simplex virus (HSV) glycoprotein D for HSV entry mediator (HVEM), a receptor expressed on T lymphocytes], tumor necrosis factor (TNF), and their specific receptors LT beta R, HVEM, and TNF receptor 1 (TNFR1) and TNFR2, form the immediate family of the larger TNF superfamily. These cytokines establish a critical communication system required for the development of secondary lymphoid tissues; however, knowledge of the target genes activated by these signaling pathways is limited. Target genes regulated by the LT alpha beta-LT beta R pathway include the tissue-organizing chemokines, CXCL13, CCL19, and CCL21, which establish cytokine circuits that regulate LT expression on lymphocytes, leading to organized lymphoid tissue. Infectious disease models have revealed that LT alpha beta pathways are also important for innate and adaptive immune responses involved in host defense. Here, regulation of interferon-beta by LT beta R and TNFR signaling may play a crucial role in certain viral infections. Regulation of autoimmune regulator in the thymus via LT beta R implicates LT/LIGHT involvement in central tolerance. Dysregulated expression of LIGHT overrides peripheral tolerance leading to T-cell-driven autoimmune disease. Blockade of TNF/LT/LIGHT pathways as an intervention in controlling autoimmune diseases is attractive, but such therapy may have risks. Thus, identifying and understanding the target genes may offer an opportunity to fine-tune inhibitory interventions.
authors.affiliation: Division of Molecular Immunology, La Jolla Institute for Allergy and Immunology, San Diego, CA 92121, USA.
authors.forename: Kirsten
authors.initials: K
authors.lastname: Schneider
authors.forename: Karen G
authors.initials: KG
authors.lastname: Potter
authors.forename: Carl F
authors.initials: CF
authors.lastname: Ware
mesh_terms: D000818:Animals; D001327:Autoimmune Diseases / Q000378:metabolism; D003141:Communicable Diseases / Q000378:metabolism; D003713:Dendritic Cells / Q000502:physiology; D005786:Gene Expression Regulation / Q000502:physiology*; D006801:Humans; D007109:Immunity / Q000502:physiology; D008198:Lymph Nodes / Q000502:physiology; D008233:Lymphotoxin-alpha / Q000502:physiology*; D008565:Membrane Proteins / Q000502:physiology*; D005810:Multigene Family; D015398:Signal Transduction / Q000502:physiology*; D013154:Spleen / Q000502:physiology; D013601:T-Lymphocytes / Q000502:physiology; D053326:Tumor Necrosis Factor Ligand Superfamily Member 14; D014409:Tumor Necrosis Factor-alpha / Q000502:physiology*
chemical_list: D008233:Lymphotoxin-alpha; D008565:Membrane Proteins; C505914:TNFSF14 protein, human; D053326:Tumor Necrosis Factor Ligand Superfamily Member 14; D014409:Tumor Necrosis Factor-alpha